The identification and validation of therapeutic targets and biomarkers are crucial for successful precision therapeutic development. Signosis offers a variety of human tissue-based research services, from preclinical to clinical development stages, aimed at effectively utilizing these targets and biomarkers. Our expertise includes the utilization of these services for small molecule, large molecule, and advanced therapeutics such as gene and cell therapies, which aid in determining target expression and localization, understanding tumor biology and cellular interactions, and characterizing new therapeutic entities.